Prosecution Insights
Last updated: October 02, 2026

Fisher Wallace Laboratories Inc.

Technology area: Medical Devices & Mechanical Engineering

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Fisher Wallace Laboratories Inc. maintains a focused presence in the Medical Devices & Mechanical Engineering technology area with 1 pending office action. This active matter is being reviewed by 1 distinct examiner, HILSMIER, HEIDI ANN. The prosecution is currently confined to 1 distinct art unit, reflecting a specialized focus within the medical device sector. This concentrated activity allows for a direct prosecution path for the company's mechanical engineering innovations.

As the busiest examiner for the portfolio, HILSMIER, HEIDI ANN is responsible for 1 pending office action. This single action constitutes the entirety of the company's current pending workload. The use of 1 distinct examiner across 1 distinct art unit for the 1 pending office action indicates a streamlined interaction with the patent office. For a practitioner, this means the company's current intellectual property goals are tied to a singular examiner relationship, which simplifies the management of the active docket but increases the impact of individual examiner discretion.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HILSMIER, HEIDI ANN 1 58.3% +61.1%

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18624083 TRANSCRANIAL ALTERNATING CURRENT STIMULATION (tACS) HILSMIER, HEIDI ANN 49d overdue

Top Art Units

Art UnitApps
3796 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18624083 TRANSCRANIAL ALTERNATING CURRENT STIMULATION (tACS) HILSMIER, HEIDI ANN 3796 §103 Non-Final OA 49d overdue Pending Apr 01, 2024

Managing Fisher Wallace Laboratories Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month